Why the study?
Do systolic time interval measurements detect early cardiac injury in patients receiving adriamycin?
Population
Patients receiving adriamycin or other chemotherapeutic agents
Comparison
Adriamycin vs Other chemotherapeutic agents
Design
Cohort
Follow-up
Up to 2 to 6 months after cessation of therapy
Authors
Loading...
May flag early adriamycin cardiotoxicity; hypothesis-generating for systolic interval monitoring, pending prospective validation.
Do systolic time interval measurements detect early cardiac injury in patients receiving adriamycin?
Systolic time interval measurements (PEP/LVET ratio) are valuable for detecting early adriamycin-induced cardiotoxicity before the onset of life-threatening heart failure.
John J. Rinehart (1974) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: